MS is a chronic, often disabling disease that attacks the central nervous system. The management of patients with MS is highly complex, and the development of disease-modifying therapies (DMTs) has dramatically altered the treatment paradigm. The virtual “MS Forum® VII: Navigating MS Care in the New Decade” is a 2-part CME/CNE series that aims to provide health care professionals with guidance on the appropriate use of therapies and strategies for delivering individualized care to patients with MS. This series will evaluate the latest clinical and real-world evidence regarding available and emerging DMTs for MS management, as well as examining emerging clinical trends and controversies in MS that may impact future clinical decision-making. The CME/CNE series will incorporate didactic presentations, interactive case-based discussions, and live question-and-answer sessions.
The intended audience for this activity is neurologists, neurology nurses, and other health care professionals involved in the management of patients with multiple sclerosis.
Upon successful completion of this activity, participants should be better able to:
Physician & Nurse
- Evaluate the latest clinical and/or real-world evidence regarding available and emerging DMTs for MS management.
- Assess the burden of comorbidities for patients with MS and implications for treatment, medication management, and quality of life.
- Examine emerging clinical trends and controversies in MS that may impact future clinical decision-making.
- Identify patients with relapsing-remitting MS (RRMS) or progressive MS in a timely manner to ensure appropriate intervention.
- Select treatment for patients with RRMS or progressive MS based on the latest clinical advances, patient risk, and evidence-based recommendations.
For more session-specific CE information, please visit the registration sites.